With so much competition in the technology sector, it takes something special to gain the attention and traction that is necessary to get a company to hit the ground running. Add blockchain technology and the health care industry to that mix, and you have even more competition. But while other blockchain-based tech companies are rising and falling in what might seem like the same instant, Stem Cell Innovations has been researching and developing ideas for its upcoming ICO launch since 2013. To understand where SCI is going, you need to understand where we’ve been. In Part 1 of this 3-part series, we’ll explore the early years and progress that has been made by SCI and its team.

It’s not often that an existing company pivots its mission and focuses on something more significant that could change the world. Truthfully, many startups are just trying to keep their head above water in the early years. With the establishment of Camden RAD LLC in 2013, no one could have known that SCI would come about just four short years later and introduce an idea that blows the minds of everyone who hears about it.

As Camden was rebranded and relaunched as Stem Cell Innovations in 2017, the start of a beautiful collaboration, relationship, friendship, and family was born — not to mention the beginning of a life-changing technology that is going to take the health care industry by storm.

Focusing on stem cell research and development, opportunities arose that made it clear that gaps existed not just in what stem cell therapies were capable of achieving, but with the way patients and doctors were interacting with such therapies. For starters, while limitations had been lifted related to stem cell research and development, use and treatments, misunderstandings surrounding the capabilities of such treatments remained murky.

To determine if those gaps could be filled, SCI set out to conduct intensive research in the stem cell industry, health care industries, and the global market at large. With visions of bridging the gap for patients and doctors, a blockchain-based technology was proposed, and the search for a rock star team was underway.

Armed with years of research and development, the team at SCI begins to formulate the first iterations of its blockchain-based platform that will enable patients to connect with stem cell specialists that can help them achieve their health-related goals. Whether patients have

Diabetes or Cancer, chronic pain or Multiple Sclerosis, having access to the specialists that can treat them with stem cells can make all the difference in the lives of millions of people around the world.

Rounding the corner to the fourth quarter of 2018, SCI is preparing for its ICO launch which will provide the capital SCI needs to make these life-changing impacts in short order.

For more information about SCI, visit www.scia.io